A patient walks in asking you to transfer their prescription from another pharmacy. For a routine maintenance medication, that’s a five-minute call. For a controlled substance, it’s a different process entirely — and getting it wrong is one of the more common ways pharmacies end up in a board complaint or DEA inquiry. Here’s how transfer rules actually work by schedule.
Schedule II: generally not transferable
Federal law does not permit the transfer of Schedule II prescriptions between pharmacies in the way non-controlled or Schedule III-V prescriptions can be transferred. A Schedule II prescription is tied to the pharmacy where it was originally presented and filled (or partially filled). If a patient wants to move a Schedule II prescription to a different pharmacy before it’s been filled, the practical options are generally limited to the prescriber issuing a new prescription directly to the new pharmacy, or — in states that participate in real-time PDMP-integrated transfer systems — a narrow set of electronic transfer mechanisms that some states have begun to permit.
Some states have started building infrastructure for limited Schedule II transfers through state PDMP systems, but this is not universal and where it exists it usually applies only to unfilled e-prescriptions, not paper prescriptions or ones already partially dispensed. Don’t assume your state allows this without confirming directly with your board — the default federal position is still no transfer.
Schedule III, IV, and V: transferable, with conditions
Schedule III-V prescriptions can be transferred between pharmacies, but subject to real conditions:
One-time transfer, generally. Under DEA regulations, a Schedule III-V prescription may typically be transferred only one time between pharmacies that don’t share a real-time online database. If both pharmacies participate in the same real-time, online database — common within chain pharmacy networks — the prescription can be transferred multiple times up to the maximum number of refills authorized, as long as each pharmacy accessing it can identify the current status.
Both pharmacists must communicate directly. The transfer must occur pharmacist-to-pharmacist (or intern/tech under direct pharmacist supervision, depending on state rules) — it isn’t something that can be handled by a technician alone in most states, and it isn’t something the patient can relay secondhand.
Required information. The transferring pharmacist typically must record and communicate: original prescription number, date of issuance, date of dispensing/refills used, drug and strength, remaining refills, patient and prescriber information, and the DEA registration number of both pharmacies involved. The receiving pharmacist records that same information along with the name of the transferring pharmacist and the pharmacy’s DEA number.
Original prescription is voided at the source. Once transferred, the original pharmacy must void the prescription in its system — it can’t be filled again there, and the remaining refills move with the transfer.
Where state law adds restrictions
Federal rules set the floor, and states frequently add stricter requirements on top:
- Some states limit even Schedule III-V transfers to a single transfer regardless of shared database participation.
- Some require the transfer to be documented in the state PDMP within a defined window.
- Some restrict which drugs within Schedule III-V can be transferred at all — gabapentin’s shifting scheduling status in various states is a good example of how quickly these categories can change; see our coverage of gabapentin scheduling by state for how that’s played out.
- Some require both pharmacies to be licensed in the same state, which becomes relevant for patients splitting time between states — a scenario also covered in our guide to non-resident pharmacy licensing.
Because state add-on rules vary this much, treat the federal framework above as a baseline, not a complete answer, and check your specific state’s regulations before processing a transfer you haven’t handled before.
Documentation and inventory implications
Every controlled substance transfer touches your inventory records, not just the prescription file. Both the transferring and receiving pharmacy need documentation that reconciles with their periodic controlled substance inventory counts — a topic covered in depth in our controlled substance inventory requirements guide. An unreconciled transfer is a common finding in DEA and state board audits, not because the transfer itself was improper, but because the paper trail didn’t match the physical count.
Keep transfer records for the same retention period your state requires for other controlled substance records — typically a minimum of two years, though some states require longer. This article describes general practice and is not a substitute for reviewing your specific state’s pharmacy practice act and current DEA guidance before processing a transfer.
Tracking controlled substance rule changes across every state where you’re licensed shouldn’t require checking each board’s website individually. See how RxByState keeps you current →